Shanghai Titan Scientific Co., Ltd. (SHA:688133)
China · Delayed Price · Currency is CNY 19.14
-1.19 (-5.85%)
Sep 11, 2026, 10:45 AM CST
Shanghai Titan Scientific Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,343 | 3,641 | 2,999 | 5,468 | 11,641 | 16,638 | |
Market Cap Growth | -19.71% | 21.38% | -45.15% | -53.03% | -30.03% | 63.17% |
Enterprise Value | 4,055 | 4,484 | 3,602 | 5,539 | 11,168 | 16,472 |
Last Close Price | 20.33 | 22.14 | 18.18 | 32.87 | 69.98 | 110.14 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 232.63 | 75.35 | 93.27 | 115.58 |
Forward PE | 21.86 | 30.28 | 23.79 | 21.57 | 40.17 | 79.56 |
PS Ratio | 1.30 | 1.44 | 1.04 | 1.97 | 4.46 | 7.69 |
PB Ratio | 1.20 | 1.29 | 1.05 | 1.92 | 4.21 | 10.30 |
P/TBV Ratio | 1.39 | 1.50 | 1.24 | 2.19 | 4.80 | 11.98 |
P/OCF Ratio | 15.96 | 15.33 | 15.87 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.58 | 1.78 | 1.25 | 2.00 | 4.28 | 7.61 |
EV/EBITDA Ratio | 108.77 | 144.16 | 35.57 | 45.30 | 61.38 | 95.64 |
EV/EBIT Ratio | - | - | 105.42 | 67.59 | 72.22 | 105.36 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.53 | 0.58 | 0.54 | 0.41 | 0.31 | 0.29 |
Debt / EBITDA Ratio | 39.67 | 38.28 | 13.08 | 8.12 | 4.41 | 2.63 |
Net Debt / Equity Ratio | 0.23 | 0.26 | 0.18 | 0.04 | -0.20 | -0.14 |
Net Debt / EBITDA Ratio | 23.74 | 23.22 | 5.09 | 0.86 | -3.00 | -1.29 |
Net Debt / FCF Ratio | -9.79 | -15.28 | -1.76 | -0.18 | 1.21 | 0.59 |
Asset Turnover | 0.52 | 0.52 | 0.62 | 0.66 | 0.79 | 0.97 |
Inventory Turnover | 1.92 | 1.91 | 2.26 | 2.38 | 2.84 | 4.00 |
Quick Ratio | 1.06 | 1.14 | 1.29 | 1.69 | 2.38 | 1.54 |
Current Ratio | 1.82 | 1.95 | 2.15 | 2.71 | 3.53 | 2.46 |
Return on Equity (ROE) | -3.41% | -1.52% | 0.27% | 2.68% | 6.01% | 9.27% |
Return on Assets (ROA) | -0.93% | -0.51% | 0.46% | 1.23% | 2.94% | 4.40% |
Return on Invested Capital (ROIC) | -2.10% | -1.15% | 1.08% | 2.80% | 7.46% | 12.13% |
Return on Capital Employed (ROCE) | -2.20% | -1.20% | 1.00% | 2.50% | 5.00% | 9.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -2.49% | -0.85% | 0.43% | 1.33% | 1.07% | 0.86% |
FCF Yield | -1.93% | -1.30% | -9.73% | -10.78% | -3.87% | -2.27% |
Dividend Yield | 0.34% | - | 0.39% | 0.22% | 0.15% | 0.09% |
Payout Ratio | - | - | 432.66% | 65.61% | 32.70% | 27.41% |
Buyback Yield / Dilution | -3.73% | -0.98% | 1.64% | -5.83% | -3.72% | -26.00% |
Total Shareholder Return | -3.40% | -0.98% | 2.03% | -5.61% | -3.57% | -25.90% |